Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer

  • C. D. Runowicz
  • , J. Mandeli
  • , J. L. Speyer
  • , S. Wadler
  • , H. Hochster
  • , L. Garrison
  • , J. F. Holland
  • , J. S. Berek

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science